In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
Session

Event : ESC Congress 2017

Topic : Chronic Heart Failure - Other

  • Session type : Satellite Symposium
  • Date : 26 August 2017
  • Time : 15:30 - 16:30
  • Sponsored by AstraZeneca

4 presentations in this session

Chair’s introduction - Lighting the way: a new path to manage hyperkalaemia.

Event : ESC Congress 2017

  • Session : Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
  • Speaker : L Lund (Stockholm,SE)
  • Sponsored by AstraZeneca

Shedding light on the risk of moderate hyperkalaemia.

Event : ESC Congress 2017

  • Session : Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
  • Speaker : GMC Rosano (London,GB)
  • Sponsored by AstraZeneca

The new treatment pathway for hyperkalaemia.

Event : ESC Congress 2017

  • Session : Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
  • Speaker : M Kosiborod (Kansas,US)
  • Sponsored by AstraZeneca

Panel Q&A - Discussion - Lighting the way: a new path to manage hyperkalaemia.

Event : ESC Congress 2017

  • Session : Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
  • Speaker : L Lund (Stockholm,SE), GMC Rosano (London,GB), M Kosiborod (Kansas,US)
  • Sponsored by AstraZeneca

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are